Community-Led COVID-19 Testing Intervention to Address Mistrust

NCT ID: NCT07166770

Last Updated: 2025-09-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

56 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-27

Study Completion Date

2026-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this adapted intervention study is to assess how community-led group discussions about health-related topics may alter beliefs and intentions regarding healthcare recommendations, such as COVID-19 testing and vaccination.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Eligible participants will be randomized to intervention or control group. Intervention group participants will meet virtually with other community member participants in small discussion groups once a week for 75 minutes over the course of 14 weeks. The online discussion groups will be led by peer mentor facilitators and supported by a research team member. Discussion topics will include current events and other health related topics. Control group participants will not meet in weekly discussion groups. At approximately the 0 weeks, 14 weeks, and 18 weeks time points, all participants will answer online surveys about health related topics. At the 14 weeks and 18 weeks time points, all participants will also be asked to self-administer a COVID-19 test that investigators provide.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19 Trust

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants randomly assigned to intervention or control group; repeated measure assessments at 0 weeks, 14 weeks, and 18 weeks
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

non-intervention control (participants complete surveys only)

Group Type NO_INTERVENTION

No interventions assigned to this group

Intervention

Participants engage in weekly community-led small group discussions about health-related topics and answer surveys at 0, 14, and 18 week time points

Group Type EXPERIMENTAL

Community-led discussion

Intervention Type BEHAVIORAL

Participants engage in weekly community-led small group discussions about health related topics

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Community-led discussion

Participants engage in weekly community-led small group discussions about health related topics

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years or older
* Resident of one of the 9 housing authority agencies
* Willing to participate in Zoom meetings and complete online assessments at baseline, 14-week, and 18-week timepoints
* Ability to read, speak, and understand English

Exclusion Criteria

* May not have participated in Study 1
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Old Dominion University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kelli J. England

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kelli J England, PhD

Role: PRINCIPAL_INVESTIGATOR

Old Dominion University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Macon & Joan Brock Virginia Health Institute at Old Dominion University

Norfolk, Virginia, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kelli J England, PhD

Role: CONTACT

757-446-7252

Brynn E Sheehan, PhD

Role: CONTACT

757-446-7052

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Kelli J England, PhD

Role: primary

757-446-7252

Betsy C Conner, CIP

Role: backup

757-446-5854

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

22-10-FB-0215 - Study 2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

COVID-19 Booster Readiness Survey
NCT05529030 COMPLETED NA
Minnesota COVID-19 Testing Project
NCT04568889 COMPLETED NA